ENDONOVO THERAPEUTICS, INC. Shareholders' Equity
ENDONOVO THERAPEUTICS, INC. (ENDV) had Shareholders' Equity of -$22.96 million as of 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-12-29
- 2023-09-30: Stockholders' Equity Attributable to Parent -$22.96M.
- 2023-06-30: Stockholders' Equity Attributable to Parent -$22.41M; Stockholders' Equity Attributable to Parent as first filed -$22.20M.
- 2023-03-31: Stockholders' Equity Attributable to Parent -$24.37M.
- 2022-12-31: Stockholders' Equity Attributable to Parent -$32.18M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-09-30 | -$22.96M 10-Q · filed 2023-12-29 | |
| 2023-06-30 | -$22.41M 10-Q · filed 2023-12-29 | -$22.20M 10-Q · filed 2023-08-21 |
| 2023-03-31 | -$24.37M 10-Q · filed 2023-12-29 | |
| 2022-12-31 | -$32.18M 10-Q · filed 2023-12-29 | |
| 2022-09-30 | -$19.61M 10-Q · filed 2023-12-29 | |
| 2022-06-30 | -$19.16M 10-Q · filed 2023-12-29 | |
| 2022-03-31 | -$18.04M 10-Q · filed 2023-12-29 | |
| 2021-12-31 | -$15.77M 10-Q · filed 2023-12-29 | |
| 2021-09-30 | -$18.22M 10-Q · filed 2022-11-21 | |
| 2021-06-30 | -$16.98M 10-Q · filed 2022-11-21 | |
| 2021-03-31 | -$15.97M 10-Q · filed 2022-11-21 | |
| 2020-12-31 | -$14.37M 10-K · filed 2023-04-17 | |
| 2020-09-30 | -$12.76M 10-Q · filed 2021-11-19 | |
| 2020-06-30 | -$12.18M 10-Q · filed 2021-11-19 | |
| 2020-03-31 | -$11.14M 10-Q · filed 2021-11-19 | |
| 2019-12-31 | -$20.50M 10-K · filed 2022-04-14 | |
| 2019-09-30 | -$16.57M 10-Q · filed 2020-11-19 | |
| 2019-06-30 | -$16.25M 10-Q · filed 2020-11-19 | |
| 2019-03-31 | -$11.62M 10-Q · filed 2020-11-19 | |
| 2018-12-31 | -$11.39M 10-K · filed 2021-04-13 | |
| 2018-09-30 | -$14.08M 10-Q · filed 2019-11-19 | |
| 2018-06-30 | -$9.12M 10-Q · filed 2019-11-19 | |
| 2018-03-31 | -$8.62M 10-Q · filed 2019-11-19 | |
| 2017-12-31 | -$9.55M 10-K · filed 2020-05-04 | |
| 2017-09-30 | -$13.18M 10-Q/A · filed 2017-11-09 | |
| 2017-06-30 | -$9.15M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | -$13.07M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$8.56M 10-K · filed 2019-04-15 | |
| 2016-09-30 | -$8.52M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$7.25M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$9.01M 10-Q · filed 2016-05-27 | |
| 2015-12-31 | -$9.28M 10-K · filed 2018-04-06 | -$7.59M 10-K · filed 2016-04-05 |
| 2015-09-30 | -$5.93M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | -$5.40M 10-Q · filed 2015-08-19 | |
| 2015-03-31 | -$4.84M 10-Q · filed 2015-06-15 | |
| 2014-12-31 | -$4.69M 10-K · filed 2017-04-17 | |
| 2013-12-31 | -$4.13M 10-K · filed 2016-05-17 | |
| 2013-09-30 | -$3.46M 10-Q · filed 2013-12-18 | |
| 2013-06-30 | -$3.02M 10-Q/A · filed 2013-08-28 | |
| 2013-03-31 | -$2.39M 10-Q/A · filed 2013-06-21 | |
| 2012-12-31 | -$1.88M 10-K · filed 2015-06-15 | |
| 2012-09-30 | -$1.43M 10-Q · filed 2012-11-29 | |
| 2012-06-30 | -$1.12M 10-Q · filed 2012-08-20 | |
| 2012-03-31 | -$718.73K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | -$447.23K 10-K/A · filed 2013-05-03 | $71.96K 10-K · filed 2012-04-13 |
| 2011-08-31 | $0.00 10-K/A · filed 2013-05-03 | |
| 2010-12-31 | $166.05K 10-K · filed 2012-04-13 | |
| 2009-12-31 | $235.45K 10-K · filed 2012-04-13 |